New emerging treatments in multiple myeloma

Natural killer immunity and the cancer immunome

Novel strategy could help overcome resistance to radiotherapy in metastatic melanoma

Interim WINTHER study findings provide lessons for future research

Banking on biomarkers – improving the diagnosis of early stage NSCLC

How can a systems biology approach aid precision cancer medicine?

Personalised, genomic-guided combination therapy could transform early disease management in ovarian and breast cancer

What can T-cells see on human cancer?

Moving precision medicine for lung cancer into the adjuvant setting

WIN Symposium 2015 highlights

Next generation of trials with targeted agents

The importance of target expression in personalised medicine